Trials / Active Not Recruiting
Active Not RecruitingNCT02991677
Exercise Effect on Chemotherapy-Induced Neuropathic Pain
Exercise Effect on Chemotherapy-Induced Neuropathic Pain, Peripheral Nerve Fibers
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Baltimore VA Medical Center · Federal
- Sex
- All
- Age
- 21 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Chemotherapy-induced peripheral neuropathy (CIPN) continues to be a serious healthcare concern. It is painful, persistent, resistant to conventional pain therapies, and results in long-term suffering and decreased quality of life for many cancer survivors. The role of exercise to decrease CIPN-related neuropathic pain (CIPN-NP) will be investigated, with the goal of identifying the mechanisms associated with this therapeutic approach to manage CIPN-NP.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | aerobic exercise intervention | Exercise physiologist supervised walking or running on the treadmill 3 times weekly for 12 weeks. |
| OTHER | control group | weekly contact by study staff with survivorship information offered not related to neuropathy. |
| BEHAVIORAL | resistive training | Exercise physiologist supervised upper and lower extremity resistive training 3 times weekly for 12 weeks |
Timeline
- Start date
- 2018-03-01
- Primary completion
- 2025-06-01
- Completion
- 2025-12-01
- First posted
- 2016-12-13
- Last updated
- 2024-08-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02991677. Inclusion in this directory is not an endorsement.